Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Barinthus Biotherapeutics (BRNS) Short-Term Debt repayments (2022)

Barinthus Biotherapeutics (BRNS) has disclosed Short-Term Debt repayments for 1 consecutive years, with $159000.0 as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Short-Term Debt repayments changed N/A year-over-year to $159000.0, compared with a TTM value of $159000.0 through Dec 2022, changed N/A, and an annual FY2022 reading of $159000.0, changed N/A over the prior year.
  • Short-Term Debt repayments was $159000.0 for Q1 2022 at Barinthus Biotherapeutics.
  • Across five years, Short-Term Debt repayments topped out at $159000.0 in Q1 2022 and bottomed at $159000.0 in Q1 2022.